BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 20232582)

  • 1. Treating photodamage of the décolletage area with a novel copper zinc malonate complex plus hydroquinone and tretinoin.
    Leyden JJ; Parr L
    J Drugs Dermatol; 2010 Mar; 9(3):220-6. PubMed ID: 20232582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigator-Blinded, Single-Center Study to Evaluate the Efficacy and Tolerability of a 4% Hydroquinone Skin Care System Plus 0.02% Tretinoin Cream in Mild-to-Moderate Melasma and Photodamage.
    Rendon M; Dryer L
    J Drugs Dermatol; 2016 Apr; 15(4):466-75. PubMed ID: 27050702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel approach to the treatment of hyperpigmented photodamaged skin: 4% hydroquinone/0.3% retinol versus tretinoin 0.05% emollient cream.
    Draelos ZD
    Dermatol Surg; 2005 Jul; 31(7 Pt 2):799-804. PubMed ID: 16029670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of hydroquinone-free and hydroquinone-based hyperpigmentation regimens in treating facial hyperpigmentation and photoaging.
    Fabi SG; Goldman MP
    J Drugs Dermatol; 2013 Mar; 12(3):S32-7. PubMed ID: 23545931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tazarotene 0.1% cream versus tretinoin 0.05% emollient cream in the treatment of photodamaged facial skin: a multicenter, double-blind, randomized, parallel-group study.
    Lowe N; Gifford M; Tanghetti E; Poulin Y; Goldman M; Tse Y; Yamauchi P; Rosenzweig H; Kang S
    J Cosmet Laser Ther; 2004 Jun; 6(2):79-85. PubMed ID: 15203997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Evaluation of a 4% Hydroquinone + 1% Retinol Treatment Regimen for Improving Melasma and Photodamage in Fitzpatrick Skin Types III-VI.
    Rendon MI; Barkovic S
    J Drugs Dermatol; 2016 Nov; 15(11):1435-1441. PubMed ID: 28095558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Firming Neck Cream Containing N-Acetyl Glucosamine Significantly Improves Signs of Aging on the Challenging Neck and Décolletage.
    Schlessinger J; Green B; Edison BL; Murphy L; Sabherwal Y
    J Drugs Dermatol; 2016 Jan; 15(1):47-52. PubMed ID: 26741381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicenter, randomized, double-blind trial of tazarotene 0.1% cream in the treatment of photodamage.
    Kang S; Krueger GG; Tanghetti EA; Lew-Kaya D; Sefton J; Walker PS; Gibson JR;
    J Am Acad Dermatol; 2005 Feb; 52(2):268-74. PubMed ID: 15692472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, double-blind, controlled comparative trial of the anti-aging properties of non-prescription tri-retinol 1.1% vs. prescription tretinoin 0.025%.
    Ho ET; Trookman NS; Sperber BR; Rizer RL; Spindler R; Sonti S; Gotz V; Mehta R
    J Drugs Dermatol; 2012 Jan; 11(1):64-9. PubMed ID: 22206079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blind, split-face study comparing the efficacy and tolerability of three retinol-based products vs. three tretinoin-based products in subjects with moderate to severe facial photodamage.
    Babcock M; Mehta RC; Makino ET
    J Drugs Dermatol; 2015 Jan; 14(1):24-30. PubMed ID: 25607905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of 0.1% tazarotene cream for the treatment of photodamage: a 12-month multicenter, randomized trial.
    Phillips TJ; Gottlieb AB; Leyden JJ; Lowe NJ; Lew-Kaya DA; Sefton J; Walker PS; Gibson JR;
    Arch Dermatol; 2002 Nov; 138(11):1486-93. PubMed ID: 12437455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further enhancement of facial appearance with a hydroquinone skin care system plus tretinoin in patients previously treated with botulinum toxin Type A.
    Schlessinger J; Kenkel J; Werschler P
    Aesthet Surg J; 2011 Jul; 31(5):529-39. PubMed ID: 21719866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tazarotene versus tazarotene plus hydroquinone in the treatment of photodamaged facial skin: a multicenter, double-blind, randomized study.
    Lowe N; Horwitz S; Tanghetti E; Draelos Z; Menter A
    J Cosmet Laser Ther; 2006 Sep; 8(3):121-7. PubMed ID: 16971360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tretinoin cream 0.02% for the treatment of photodamaged facial skin: a review of 2 double-blind clinical studies.
    Nyirady J; Bergfeld W; Ellis C; Levine N; Savin R; Shavin J; Voorhees JJ; Weiss J; Grossman R
    Cutis; 2001 Aug; 68(2):135-42. PubMed ID: 11534915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy evaluation of tretinoin cream 0.02% for the reduction of photodamage: a pilot study.
    Kircik LH
    J Drugs Dermatol; 2012 Jan; 11(1):83-90. PubMed ID: 22206082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tazarotene 0.1% cream for the treatment of photodamage.
    Phillips TJ
    Skin Therapy Lett; 2004 Apr; 9(4):1-2. PubMed ID: 15146262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of hydroquinone cream (USP 4%) used alone or in combination with salicylic acid peels in improving photodamage on the neck and upper chest.
    Gladstone HB; Nguyen SL; Williams R; Ottomeyer T; Wortzman M; Jeffers M; Moy RL
    Dermatol Surg; 2000 Apr; 26(4):333-7. PubMed ID: 10759820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of two anti-acne/anti-aging treatments in subjects with photodamaged skin and mild to moderate acne vulgaris.
    Kircik LH; Dahl A; Yatskayer M; Raab S; Oresajo C
    J Drugs Dermatol; 2012 Jun; 11(6):737-40. PubMed ID: 22648221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a prescription strength 4% hydroquinone/10% L-ascorbic acid treatment system for normal to oily skin.
    Bruce S; Watson J
    J Drugs Dermatol; 2011 Dec; 10(12):1455-61. PubMed ID: 22134571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brightening and Improvement of Facial Skin Quality in Healthy Female Subjects With Moderate Hyperpigmentation or Dark Spots and Moderate Facial Aging.
    Serra M; Bohnert K; Narda M; Granger C; Sadick N
    J Drugs Dermatol; 2018 Dec; 17(12):1310-1315. PubMed ID: 30586263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.